| Value | ₹0.31 Cr |
|---|---|
| Order from | Internal Revenue Service |
BSE filing, NSE: DRREDDY. Summary written from the filing by ALFA Finder's alert engine.
Dr. Reddy's Laboratories Ltd: key numbers
- Share price
- ₹1,352.00
- Market cap
- ₹1,12,848 Cr
- Revenue (annual)
- ₹33,700 Cr
- Net profit (annual)
- ₹4,196 Cr
- P/E (TTM)
- 40.3×Sector 45.9×
- Promoter holding
- 26.63%-0.01% QoQ
- FII holding
- 20.30%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Reddy's Laboratories Ltd
All →Dr. Reddy's Laboratories Business Update
Dr Reddy's says USFDA closed its PAI and GMP inspection at Srikakulam FTO-SEZ Process Unit-02 with VAI classification. The outcome is closed with no monetary penalty.
Dr. Reddy's Laboratories Earnings Call Transcript: Key Takeaways
Revenue declined 1.5% YoY as lower Revlimid sales in North America offset strong double-digit growth in base business and emerging markets.
- Call
- Guides 25% growth
Dr. Reddy's Laboratories Management Change
Dr Reddy's appointed Akhil Ravi as Head API and Services and Senior Management Personnel, effective 13 November 2026. Ravi is the son-in-law of co-chairman G V Prasad.
Dr. Reddy's Laboratories Investor Presentation: Key Takeaways
Q2FY27 revenue ₹8,671 Cr (-1.5% YoY), EBITDA ₹1,783 Cr (20.6%), PAT ₹925 Cr (-36% YoY). Management stresses double-digit base-business growth excluding lenalidomide in North America.
Dr. Reddy's Laboratories Q2 FY27 Results: Net Profit ₹913.2 Cr, Down 31.7% YoY
Dr. Reddy's Laboratories Ltd reported revenue from operations of ₹8,698 Cr (-1.5% YoY) and net profit of ₹913.2 Cr (-31.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹913.2 Cr · -31.7% YoY
Dr. Reddy's Laboratories Other Announcement
Dr. Reddy's Laboratories Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, including notes on significant beneficial ownership.
Other legal & regulatory announcements
All →Jyoti Legal & Regulatory
Jyoti Ltd received a rectification order from the Income Tax Department for AY 2020-21. The order levies an income tax demand of Rs.6.82 Crore including interest.
- Value
- ₹6.82 Cr
ICICI Bank Legal & Regulatory
ICICI Bank received an Order in Appeal confirming a GST penalty of Rs.6.95 lakh. The bank will appeal the order within prescribed timelines.
- Value
- ₹0.07 Cr
DIC India Legal & Regulatory
DIC India's GST demand for FY 2021-22 was reduced on appeal to Rs.1.29 lakh from Rs.4.68 lakh. The company is evaluating the order.
- Value
- ₹0.01 Cr
Blue Star Legal & Regulatory
Blue Star's Dubai Court of Appeal dismissed WJT's application to annul the arbitration award in the company's favour. WJT may still appeal the award.
- Value
- ₹461.7 Cr
Mahalaxmi Rubtech Legal & Regulatory
Mahalaxmi Rubtech was fined by BSE and NSE for delayed XBRL voting results. The fines of Rs.11,800 each have been paid and the results uploaded.
- Value
- ₹0.00 Cr
FDC Legal & Regulatory
FDC received tax orders giving an aggregate refund of Rs.37.22 Crore for AY 2014-15 and AY 2012-13. The refund follows favourable CIT(A) orders on the company's appeals.
- Value
- ₹37.22 Cr